Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children

Hye Eun Kim, Jae Jung Kim, Myung Ki Han, Kyung Yil Lee, Min Seob Song, Hyoung Doo Lee, Dong Soo Kim, Jeong Jin Yu, In Sook Park, Sin Weon Yun, Young Mi Hong, Giyoung Jang, Jong Keuk Lee

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

High-dose intravenous immunoglobulin (IVIG) therapy is the highly effective and standard treatment for Kawasaki disease (KD). However, ~20 % of KD patients have persistent fever or recurrence of fever after the initial IVIG treatment, which increases the risk for coronary artery lesions (CALs). Furthermore, the mechanism of IVIG resistance in KD patients still is unknown. The number of CC chemokine ligand 3-like 1 (CCL3L1) gene copies is reported to be associated with KD and IVIG resistance in Japanese patients. In addition, the authors observed significant upregulation of the CCL3L1 gene expression after in vitro immunoglobulin treatment in B cell lines derived from KD patients. Therefore, this study of 459 KD patients and 496 healthy control subjects tested whether the number of CCL3L1 gene copies is associated with a risk of KD, CALs, and/or IVIG resistance in Korean KD patients. However, the number of CCL3L1 gene copies was not associated with KD (P = 0.18), CAL formation (P = 0.062), or the IVIG resistance (P = 0.90). Therefore, the results indicate that the number of CCL3L1 gene copies does not have a role in susceptibility to KD or CALs nor with IVIG resistance in Korean KD patients.

Original languageEnglish
Pages (from-to)1259-1263
Number of pages5
JournalPediatric Cardiology
Volume33
Issue number8
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

CC Chemokines
Mucocutaneous Lymph Node Syndrome
Intravenous Immunoglobulins
Ligands
Genes
Coronary Vessels
Fever
Passive Immunization
Immunoglobulins
Healthy Volunteers
B-Lymphocytes
Up-Regulation
Therapeutics

Keywords

  • CC chemokine ligand 3-like 1 (CCL3L1)
  • Chemokine
  • Copy number variation (CNV)
  • Kawasaki disease (KD)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Kim, H. E., Kim, J. J., Han, M. K., Lee, K. Y., Song, M. S., Lee, H. D., ... Lee, J. K. (2012). Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children. Pediatric Cardiology, 33(8), 1259-1263. https://doi.org/10.1007/s00246-012-0289-5

Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children. / Kim, Hye Eun; Kim, Jae Jung; Han, Myung Ki; Lee, Kyung Yil; Song, Min Seob; Lee, Hyoung Doo; Kim, Dong Soo; Yu, Jeong Jin; Park, In Sook; Yun, Sin Weon; Hong, Young Mi; Jang, Giyoung; Lee, Jong Keuk.

In: Pediatric Cardiology, Vol. 33, No. 8, 01.12.2012, p. 1259-1263.

Research output: Contribution to journalArticle

Kim, HE, Kim, JJ, Han, MK, Lee, KY, Song, MS, Lee, HD, Kim, DS, Yu, JJ, Park, IS, Yun, SW, Hong, YM, Jang, G & Lee, JK 2012, 'Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children', Pediatric Cardiology, vol. 33, no. 8, pp. 1259-1263. https://doi.org/10.1007/s00246-012-0289-5
Kim, Hye Eun ; Kim, Jae Jung ; Han, Myung Ki ; Lee, Kyung Yil ; Song, Min Seob ; Lee, Hyoung Doo ; Kim, Dong Soo ; Yu, Jeong Jin ; Park, In Sook ; Yun, Sin Weon ; Hong, Young Mi ; Jang, Giyoung ; Lee, Jong Keuk. / Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children. In: Pediatric Cardiology. 2012 ; Vol. 33, No. 8. pp. 1259-1263.
@article{d9fcb490506448b4819615bacbf7bc53,
title = "Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children",
abstract = "High-dose intravenous immunoglobulin (IVIG) therapy is the highly effective and standard treatment for Kawasaki disease (KD). However, ~20 {\%} of KD patients have persistent fever or recurrence of fever after the initial IVIG treatment, which increases the risk for coronary artery lesions (CALs). Furthermore, the mechanism of IVIG resistance in KD patients still is unknown. The number of CC chemokine ligand 3-like 1 (CCL3L1) gene copies is reported to be associated with KD and IVIG resistance in Japanese patients. In addition, the authors observed significant upregulation of the CCL3L1 gene expression after in vitro immunoglobulin treatment in B cell lines derived from KD patients. Therefore, this study of 459 KD patients and 496 healthy control subjects tested whether the number of CCL3L1 gene copies is associated with a risk of KD, CALs, and/or IVIG resistance in Korean KD patients. However, the number of CCL3L1 gene copies was not associated with KD (P = 0.18), CAL formation (P = 0.062), or the IVIG resistance (P = 0.90). Therefore, the results indicate that the number of CCL3L1 gene copies does not have a role in susceptibility to KD or CALs nor with IVIG resistance in Korean KD patients.",
keywords = "CC chemokine ligand 3-like 1 (CCL3L1), Chemokine, Copy number variation (CNV), Kawasaki disease (KD)",
author = "Kim, {Hye Eun} and Kim, {Jae Jung} and Han, {Myung Ki} and Lee, {Kyung Yil} and Song, {Min Seob} and Lee, {Hyoung Doo} and Kim, {Dong Soo} and Yu, {Jeong Jin} and Park, {In Sook} and Yun, {Sin Weon} and Hong, {Young Mi} and Giyoung Jang and Lee, {Jong Keuk}",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s00246-012-0289-5",
language = "English",
volume = "33",
pages = "1259--1263",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children

AU - Kim, Hye Eun

AU - Kim, Jae Jung

AU - Han, Myung Ki

AU - Lee, Kyung Yil

AU - Song, Min Seob

AU - Lee, Hyoung Doo

AU - Kim, Dong Soo

AU - Yu, Jeong Jin

AU - Park, In Sook

AU - Yun, Sin Weon

AU - Hong, Young Mi

AU - Jang, Giyoung

AU - Lee, Jong Keuk

PY - 2012/12/1

Y1 - 2012/12/1

N2 - High-dose intravenous immunoglobulin (IVIG) therapy is the highly effective and standard treatment for Kawasaki disease (KD). However, ~20 % of KD patients have persistent fever or recurrence of fever after the initial IVIG treatment, which increases the risk for coronary artery lesions (CALs). Furthermore, the mechanism of IVIG resistance in KD patients still is unknown. The number of CC chemokine ligand 3-like 1 (CCL3L1) gene copies is reported to be associated with KD and IVIG resistance in Japanese patients. In addition, the authors observed significant upregulation of the CCL3L1 gene expression after in vitro immunoglobulin treatment in B cell lines derived from KD patients. Therefore, this study of 459 KD patients and 496 healthy control subjects tested whether the number of CCL3L1 gene copies is associated with a risk of KD, CALs, and/or IVIG resistance in Korean KD patients. However, the number of CCL3L1 gene copies was not associated with KD (P = 0.18), CAL formation (P = 0.062), or the IVIG resistance (P = 0.90). Therefore, the results indicate that the number of CCL3L1 gene copies does not have a role in susceptibility to KD or CALs nor with IVIG resistance in Korean KD patients.

AB - High-dose intravenous immunoglobulin (IVIG) therapy is the highly effective and standard treatment for Kawasaki disease (KD). However, ~20 % of KD patients have persistent fever or recurrence of fever after the initial IVIG treatment, which increases the risk for coronary artery lesions (CALs). Furthermore, the mechanism of IVIG resistance in KD patients still is unknown. The number of CC chemokine ligand 3-like 1 (CCL3L1) gene copies is reported to be associated with KD and IVIG resistance in Japanese patients. In addition, the authors observed significant upregulation of the CCL3L1 gene expression after in vitro immunoglobulin treatment in B cell lines derived from KD patients. Therefore, this study of 459 KD patients and 496 healthy control subjects tested whether the number of CCL3L1 gene copies is associated with a risk of KD, CALs, and/or IVIG resistance in Korean KD patients. However, the number of CCL3L1 gene copies was not associated with KD (P = 0.18), CAL formation (P = 0.062), or the IVIG resistance (P = 0.90). Therefore, the results indicate that the number of CCL3L1 gene copies does not have a role in susceptibility to KD or CALs nor with IVIG resistance in Korean KD patients.

KW - CC chemokine ligand 3-like 1 (CCL3L1)

KW - Chemokine

KW - Copy number variation (CNV)

KW - Kawasaki disease (KD)

UR - http://www.scopus.com/inward/record.url?scp=84878231590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878231590&partnerID=8YFLogxK

U2 - 10.1007/s00246-012-0289-5

DO - 10.1007/s00246-012-0289-5

M3 - Article

C2 - 22450355

AN - SCOPUS:84878231590

VL - 33

SP - 1259

EP - 1263

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 8

ER -